284 related articles for article (PubMed ID: 17118412)
1. Effect of delta9-tetrahydrocannabinol on quinine palatability and AM251 on sucrose and quinine palatability using the taste reactivity test.
Jarrett MM; Scantlebury J; Parker LA
Physiol Behav; 2007 Feb; 90(2-3):425-30. PubMed ID: 17118412
[TBL] [Abstract][Full Text] [Related]
2. Effect of Delta9-tetrahydrocannabinol on sucrose palatability as measured by the taste reactivity test.
Jarrett MM; Limebeer CL; Parker LA
Physiol Behav; 2005 Nov; 86(4):475-9. PubMed ID: 16185725
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid facilitation of behavioral and biochemical hedonic taste responses.
De Luca MA; Solinas M; Bimpisidis Z; Goldberg SR; Di Chiara G
Neuropharmacology; 2012 Jul; 63(1):161-8. PubMed ID: 22063718
[TBL] [Abstract][Full Text] [Related]
4. Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability.
O'Brien LD; Wills KL; Segsworth B; Dashney B; Rock EM; Limebeer CL; Parker LA
Pharmacol Biochem Behav; 2013 Jan; 103(3):597-602. PubMed ID: 23103902
[TBL] [Abstract][Full Text] [Related]
5. Discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats.
Järbe TU; Li C; Vadivel SK; Makriyannis A
Psychopharmacology (Berl); 2008 Jul; 198(4):467-78. PubMed ID: 18264696
[TBL] [Abstract][Full Text] [Related]
6. Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea.
Parker LA; Mechoulam R; Schlievert C; Abbott L; Fudge ML; Burton P
Psychopharmacology (Berl); 2003 Mar; 166(2):156-62. PubMed ID: 12528012
[TBL] [Abstract][Full Text] [Related]
7. Morphine- and naltrexone-induced modification of palatability: analysis by the taste reactivity test.
Parker LA; Maier S; Rennie M; Crebolder J
Behav Neurosci; 1992 Dec; 106(6):999-1010. PubMed ID: 1335271
[TBL] [Abstract][Full Text] [Related]
8. Fenfluramine-induced modification of palatability: analysis by the taste reactivity test.
Barnfield A; Parker LA; Davies AM; Miles C
Pharmacol Biochem Behav; 1994 Aug; 48(4):875-9. PubMed ID: 7972290
[TBL] [Abstract][Full Text] [Related]
9. The effects of lipopolysaccharide and lithium chloride on the ingestion of a bitter-sweet taste: comparing intake and palatability.
Cross-Mellor SK; Kavaliers M; Ossenkopp KP
Brain Behav Immun; 2005 Nov; 19(6):564-73. PubMed ID: 16214027
[TBL] [Abstract][Full Text] [Related]
10. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R
Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755
[TBL] [Abstract][Full Text] [Related]
11. Measurement of affective state during chronic nicotine treatment and withdrawal by affective taste reactivity in mice: the role of endocannabinoids.
Wing VC; Cagniard B; Murphy NP; Shoaib M
Biochem Pharmacol; 2009 Oct; 78(7):825-35. PubMed ID: 19540830
[TBL] [Abstract][Full Text] [Related]
12. Delta9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist delta9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats.
Järbe TU; DiPatrizio NV
Behav Pharmacol; 2005 Sep; 16(5-6):373-80. PubMed ID: 16148441
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716.
Higgs S; Williams CM; Kirkham TC
Psychopharmacology (Berl); 2003 Feb; 165(4):370-7. PubMed ID: 12447606
[TBL] [Abstract][Full Text] [Related]
14. Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain.
Bagüés A; Martín MI; Sánchez-Robles EM
Eur J Pharmacol; 2014 Dec; 745():69-75. PubMed ID: 25446925
[TBL] [Abstract][Full Text] [Related]
15. Endogenous opioids are necessary for benzodiazepine palatability enhancement: naltrexone blocks diazepam-induced increase of sucrose-'liking'.
Richardson DK; Reynolds SM; Cooper SJ; Berridge KC
Pharmacol Biochem Behav; 2005 Jul; 81(3):657-63. PubMed ID: 15961147
[TBL] [Abstract][Full Text] [Related]
16. Effect of delta9-tetrahydrocannabinol on phosphorylated CREB in rat cerebellum: an immunohistochemical study.
Casu MA; Pisu C; Sanna A; Tambaro S; Spada GP; Mongeau R; Pani L
Brain Res; 2005 Jun; 1048(1-2):41-7. PubMed ID: 15913574
[TBL] [Abstract][Full Text] [Related]
17. Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats.
Rubino T; Sala M; Viganò D; Braida D; Castiglioni C; Limonta V; Guidali C; Realini N; Parolaro D
Neuropsychopharmacology; 2007 Sep; 32(9):2036-45. PubMed ID: 17287821
[TBL] [Abstract][Full Text] [Related]
18. Local administration of delta9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: a peripheral cannabinoid action.
Ko MC; Woods JH
Psychopharmacology (Berl); 1999 Apr; 143(3):322-6. PubMed ID: 10353438
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid agonists and antagonists modulate lithium-induced conditioned gaping in rats.
Parker LA; Mechoulam R
Integr Physiol Behav Sci; 2003; 38(2):133-45. PubMed ID: 14527182
[TBL] [Abstract][Full Text] [Related]
20. Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation.
Hoffman AF; Oz M; Yang R; Lichtman AH; Lupica CR
Learn Mem; 2007; 14(1-2):63-74. PubMed ID: 17202425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
